Trials / Completed
CompletedNCT07195396
To Collect Enriched Human Serum Following Hydrolyzed Collagen Intake
A Randomized, Double-blind, Moncentric, Cross-over Study to Collect Human Serum After Ingestion of Hydrolyzed Collagen Peptides.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Rousselot BVBA · Industry
- Sex
- Female
- Age
- 35 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This randomized, double-blind, monocentric, five-way cross-over study aims to collect human serum and plasma samples at 1 and 2 hours after ingestion of hydrolyzed collagen peptides. The enriched sera will be used for ex vivo/ in vitro experiments on skin keratinocytes, fibroblasts, and other cell types to explore the beneficial effects of bioactive collagen peptides. Blood will also be analyzed for amino acid profiles and collagen-derived peptides.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Collagen hydrolysate 1 | 10g single oral dose dissolved in water |
| DIETARY_SUPPLEMENT | Collagen hydrolysate 2 | 10g single oral dose dissolved in water |
| DIETARY_SUPPLEMENT | Collagen hydrolysate 3 | 10g single oral dose dissolved in water |
| DIETARY_SUPPLEMENT | Collagen hydrolysate 4 | 10g single oral dose dissolved in water |
| DIETARY_SUPPLEMENT | Collagen hydrolysate 5 | 10g single oral dose dissolved in water |
Timeline
- Start date
- 2025-10-22
- Primary completion
- 2025-12-22
- Completion
- 2025-12-22
- First posted
- 2025-09-26
- Last updated
- 2026-01-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT07195396. Inclusion in this directory is not an endorsement.